Finding 502171 (2020-005)

Significant Deficiency Repeat Finding
Requirement
I
Questioned Costs
-
Year
2020
Accepted
2024-10-10

AI Summary

  • Core Issue: AAPT did not consistently follow procurement policies, leading to inadequate documentation of bids and selection processes.
  • Impacted Requirements: Compliance with 2 CFR 200.317-326, which mandates cost or price analysis for all procurement actions.
  • Recommended Follow-Up: Update procurement policies to ensure documentation of contractor selection and justification for lack of competition; completion expected by November 2024.

Finding Text

Finding 2020-005: Procurement Federal Program: Research and Development Cluster (Education and Human Resources) Assistance Listing Number and Title: 47.076 STEM Education Name of Federal Agency, Pass Through Entity (when applicable), Award Number and Year: National Science Foundation: 1431638 (9/1/2014 – 8/31/2022), 1524963 (11/1/2015 – 9/30/2021), 1500529 (9/1/2015 – 8/31/2022), 1624185 (9/16/2016 – 8/31/2022), 1640791 (9/15/2016 – 8/31/2022), 1720869 (5/15/2017 – 4/30/2022), 1726113 (8/1/2017 – 9/30/2023), 1645003 (3/15/2017 – 2/29/2020), 1821462 (7/1/2018 – 6/30/2024), 1812860 (9/1/2018 – 8/31/2020), 1940925 (1/15/2020 – 12/31/2023), 1907950 (7/1/2019 – 6/30/2024), 2015205 (4/1/2020 – 3/31/2022), 2021059 (10/1/2020 – 9/30/2024) Federal Program: Research and Development Cluster (Mathematical and Physical Sciences) Assistance Listing Number and Title: 47.049 Mathematical and Physical Sciences Name of Federal Agency, Pass Through Entity, Award Number and Year: National Science Foundation: 1821372 (10/1/2018 – 9/30/2024 pass through entity American Physical Society), 1834530 (9/1/2018 – 8/31/2025 pass through entity American Physical Society), 1938815 (8/1/2020 – 7/31/2024) Federal Program: Research and Development Cluster (Science) Assistance Listing Number and Title: 43.001 Science Name of Federal Agency, Pass Through Entity: NNX16AR36A (8/24/2016 – 8/23/2021 pass through entity Temple University of the Commonwealth System of Higher Education) Significant Deficiency in Internal Controls Over Compliance, Other matters Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Procedures articulated in 2 CFR 200.317-326, requires that for all procurement of goods and services, some form of cost or price analysis shall be made and documented in the procurement files in connection with every procurement action based on the dollar thresholds sited in the compliance code. Condition: AAPT did not consistently adhere to written policies with respect to the procurement process, as bids/quotes were not obtainable or the conclusion for selection was not documented. Cause: AAPT’s internal policies and procedures governing procurement were not consistently applied. Effect or Potential Effect: Without proper and complete procurement documentation, there is a risk that AAPT will not perform proper evaluation of each element of cost to determine reasonableness. Questioned Costs: None noted. Context: Our audit procedures consisted of internal control testwork over the cash disbursement cycle over a sample population of expenditures. We consider our sample to be representative of the population. The condition appeared to be systematic in nature. Identification as a Repeat Finding, if Applicable: 2019-004. Recommendation: We recommend that all procurement records for purchases in excess of the purchase threshold include the following, at a minimum: (a) basis for contractor/goods selection or (b) justification for lack of competition when competitive bids or offers are not obtained. Additionally, the conclusion should be clearly documented and accompanying the procurement documentation. Views of Responsible Officials and Planned Corrective Actions: Management will update current policies and procedures and review and enforce the polices. Management will be responsible for proper documentation and confirmation that all policies and procedures are followed. Management will confirm that all agreements, mou’s and contracts are property, reviewed signed and documented. Management will require all departments to document all procurements for goods and services with written cost and price analysis based on AAPT's dollar thresholds. Anticipated Completion Date: November 2024 Responsible Official: Dr. Beth Cunningham CEO, Michael Brosnan CFO

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 502144 2020-001
    Significant Deficiency
  • 502145 2020-002
    Material Weakness Repeat
  • 502146 2020-005
    Significant Deficiency Repeat
  • 502147 2020-001
    Significant Deficiency
  • 502148 2020-002
    Material Weakness Repeat
  • 502149 2020-005
    Significant Deficiency Repeat
  • 502150 2020-001
    Significant Deficiency
  • 502151 2020-002
    Material Weakness Repeat
  • 502152 2020-004
    Significant Deficiency
  • 502153 2020-005
    Significant Deficiency Repeat
  • 502154 2020-001
    Significant Deficiency
  • 502155 2020-002
    Material Weakness Repeat
  • 502156 2020-004
    Significant Deficiency
  • 502157 2020-005
    Significant Deficiency Repeat
  • 502158 2020-001
    Significant Deficiency
  • 502159 2020-002
    Material Weakness Repeat
  • 502160 2020-005
    Significant Deficiency Repeat
  • 502161 2020-006
    Significant Deficiency Repeat
  • 502162 2020-001
    Significant Deficiency
  • 502163 2020-002
    Material Weakness Repeat
  • 502164 2020-005
    Significant Deficiency Repeat
  • 502165 2020-001
    Significant Deficiency
  • 502166 2020-002
    Material Weakness Repeat
  • 502167 2020-004
    Significant Deficiency
  • 502168 2020-005
    Significant Deficiency Repeat
  • 502169 2020-001
    Significant Deficiency
  • 502170 2020-002
    Material Weakness Repeat
  • 502172 2020-001
    Significant Deficiency
  • 502173 2020-002
    Material Weakness Repeat
  • 502174 2020-005
    Significant Deficiency Repeat
  • 502175 2020-001
    Significant Deficiency
  • 502176 2020-002
    Material Weakness Repeat
  • 502177 2020-003
    Material Weakness Repeat
  • 502178 2020-005
    Significant Deficiency Repeat
  • 502179 2020-001
    Significant Deficiency
  • 502180 2020-002
    Material Weakness Repeat
  • 502181 2020-003
    Material Weakness Repeat
  • 502182 2020-005
    Significant Deficiency Repeat
  • 502183 2020-001
    Significant Deficiency
  • 502184 2020-002
    Material Weakness Repeat
  • 502185 2020-005
    Significant Deficiency Repeat
  • 502186 2020-001
    Significant Deficiency
  • 502187 2020-002
    Material Weakness Repeat
  • 502188 2020-005
    Significant Deficiency Repeat
  • 502189 2020-001
    Significant Deficiency
  • 502190 2020-002
    Material Weakness Repeat
  • 502191 2020-005
    Significant Deficiency Repeat
  • 502192 2020-001
    Significant Deficiency
  • 502193 2020-002
    Material Weakness Repeat
  • 502194 2020-005
    Significant Deficiency Repeat
  • 502195 2020-001
    Significant Deficiency
  • 502196 2020-002
    Material Weakness Repeat
  • 502197 2020-005
    Significant Deficiency Repeat
  • 502198 2020-001
    Significant Deficiency
  • 502199 2020-002
    Material Weakness Repeat
  • 502200 2020-005
    Significant Deficiency Repeat
  • 502201 2020-001
    Significant Deficiency
  • 502202 2020-002
    Material Weakness Repeat
  • 502203 2020-005
    Significant Deficiency Repeat
  • 1078586 2020-001
    Significant Deficiency
  • 1078587 2020-002
    Material Weakness Repeat
  • 1078588 2020-005
    Significant Deficiency Repeat
  • 1078589 2020-001
    Significant Deficiency
  • 1078590 2020-002
    Material Weakness Repeat
  • 1078591 2020-005
    Significant Deficiency Repeat
  • 1078592 2020-001
    Significant Deficiency
  • 1078593 2020-002
    Material Weakness Repeat
  • 1078594 2020-004
    Significant Deficiency
  • 1078595 2020-005
    Significant Deficiency Repeat
  • 1078596 2020-001
    Significant Deficiency
  • 1078597 2020-002
    Material Weakness Repeat
  • 1078598 2020-004
    Significant Deficiency
  • 1078599 2020-005
    Significant Deficiency Repeat
  • 1078600 2020-001
    Significant Deficiency
  • 1078601 2020-002
    Material Weakness Repeat
  • 1078602 2020-005
    Significant Deficiency Repeat
  • 1078603 2020-006
    Significant Deficiency Repeat
  • 1078604 2020-001
    Significant Deficiency
  • 1078605 2020-002
    Material Weakness Repeat
  • 1078606 2020-005
    Significant Deficiency Repeat
  • 1078607 2020-001
    Significant Deficiency
  • 1078608 2020-002
    Material Weakness Repeat
  • 1078609 2020-004
    Significant Deficiency
  • 1078610 2020-005
    Significant Deficiency Repeat
  • 1078611 2020-001
    Significant Deficiency
  • 1078612 2020-002
    Material Weakness Repeat
  • 1078613 2020-005
    Significant Deficiency Repeat
  • 1078614 2020-001
    Significant Deficiency
  • 1078615 2020-002
    Material Weakness Repeat
  • 1078616 2020-005
    Significant Deficiency Repeat
  • 1078617 2020-001
    Significant Deficiency
  • 1078618 2020-002
    Material Weakness Repeat
  • 1078619 2020-003
    Material Weakness Repeat
  • 1078620 2020-005
    Significant Deficiency Repeat
  • 1078621 2020-001
    Significant Deficiency
  • 1078622 2020-002
    Material Weakness Repeat
  • 1078623 2020-003
    Material Weakness Repeat
  • 1078624 2020-005
    Significant Deficiency Repeat
  • 1078625 2020-001
    Significant Deficiency
  • 1078626 2020-002
    Material Weakness Repeat
  • 1078627 2020-005
    Significant Deficiency Repeat
  • 1078628 2020-001
    Significant Deficiency
  • 1078629 2020-002
    Material Weakness Repeat
  • 1078630 2020-005
    Significant Deficiency Repeat
  • 1078631 2020-001
    Significant Deficiency
  • 1078632 2020-002
    Material Weakness Repeat
  • 1078633 2020-005
    Significant Deficiency Repeat
  • 1078634 2020-001
    Significant Deficiency
  • 1078635 2020-002
    Material Weakness Repeat
  • 1078636 2020-005
    Significant Deficiency Repeat
  • 1078637 2020-001
    Significant Deficiency
  • 1078638 2020-002
    Material Weakness Repeat
  • 1078639 2020-005
    Significant Deficiency Repeat
  • 1078640 2020-001
    Significant Deficiency
  • 1078641 2020-002
    Material Weakness Repeat
  • 1078642 2020-005
    Significant Deficiency Repeat
  • 1078643 2020-001
    Significant Deficiency
  • 1078644 2020-002
    Material Weakness Repeat
  • 1078645 2020-005
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
47.049 Mathematical and Physical Sciences $10,562
47.076 Education and Human Resources $6,442
43.001 Science $4,172